4btu: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{STRUCTURE_4btu| PDB=4btu | SCENE= }} | |||
===factor Xa in complex with the dual thrombin-FXa inhibitor 57.=== | |||
{{ABSTRACT_PUBMED_24175584}} | |||
==Disease== | |||
[[http://www.uniprot.org/uniprot/FA10_HUMAN FA10_HUMAN]] Defects in F10 are the cause of factor X deficiency (FA10D) [MIM:[http://omim.org/entry/227600 227600]]. A hemorrhagic disease with variable presentation. Affected individuals can manifest prolonged nasal and mucosal hemorrhage, menorrhagia, hematuria, and occasionally hemarthrosis. Some patients do not have clinical bleeding diathesis.<ref>PMID:2790181</ref> <ref>PMID:1973167</ref> <ref>PMID:1985698</ref> <ref>PMID:7669671</ref> <ref>PMID:8529633</ref> <ref>PMID:7860069</ref> <ref>PMID:8845463</ref> <ref>PMID:8910490</ref> <ref>PMID:10468877</ref> <ref>PMID:10746568</ref> <ref>PMID:10739379</ref> <ref>PMID:11248282</ref> <ref>PMID:11728527</ref> <ref>PMID:12945883</ref> <ref>PMID:15650540</ref> <ref>PMID:17393015</ref> <ref>PMID:19135706</ref> | |||
==Function== | |||
[[http://www.uniprot.org/uniprot/FA10_HUMAN FA10_HUMAN]] Factor Xa is a vitamin K-dependent glycoprotein that converts prothrombin to thrombin in the presence of factor Va, calcium and phospholipid during blood clotting. | |||
==About this Structure== | |||
[[4btu]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4BTU OCA]. | |||
==Reference== | |||
<ref group="xtra">PMID:024175584</ref><references group="xtra"/><references/> | |||
[[Category: Coagulation factor Xa]] | |||
[[Category: Homo sapiens]] | |||
[[Category: Alet, N.]] | |||
[[Category: Altenburger, J M.]] | |||
[[Category: Barre, G.]] | |||
[[Category: Bocskei, Z.]] | |||
[[Category: Bono, F.]] | |||
[[Category: Briot, C.]] | |||
[[Category: Dol, F.]] | |||
[[Category: Follmann, M.]] | |||
[[Category: Hasbrand, C.]] | |||
[[Category: Herault, J P.]] | |||
[[Category: Herbert, J M.]] | |||
[[Category: Klieber, S.]] | |||
[[Category: Lassalle, G.]] | |||
[[Category: Meneyrol, J.]] | |||
[[Category: Millet, L.]] | |||
[[Category: Petit, F.]] | |||
[[Category: Rousseaux, T.]] | |||
[[Category: Sadoun, F.]] | |||
[[Category: Schaeffer, P.]] | |||
[[Category: Schreuder, H.]] | |||
[[Category: Stehlin-Gaon, C.]] | |||
[[Category: Wehner, V.]] | |||
[[Category: Chlorothiophene p1 fragment]] | |||
[[Category: Dual inhibitor]] | |||
[[Category: Factor xa inhibitor]] | |||
[[Category: Hydrolase]] | |||
[[Category: Iv antithrombotic]] | |||
[[Category: Microsomes stability]] | |||
[[Category: Oral antithrombotic]] | |||
[[Category: S3 subsite]] | |||
[[Category: Sar107375]] | |||
[[Category: Thrombin inhibitor]] | |||